Cargando…

First person – Eileen Lynch

First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms (DMM), helping early-career researchers promote themselves alongside their papers. Eileen Lynch is first author on ‘C9ORF72-related cellular pathology in skeletal myocy...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Company of Biologists Ltd 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6737961/
http://dx.doi.org/10.1242/dmm.041640
_version_ 1783450751496880128
collection PubMed
description First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms (DMM), helping early-career researchers promote themselves alongside their papers. Eileen Lynch is first author on ‘C9ORF72-related cellular pathology in skeletal myocytes derived from ALS-patient induced pluripotent stem cells’, published in DMM. Eileen is a graduate research assistant/PhD candidate in the lab of Masatoshi Suzuki at University of Wisconsin-Madison, WI, USA, investigating in vitro disease modeling of neuromuscular diseases.
format Online
Article
Text
id pubmed-6737961
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher The Company of Biologists Ltd
record_format MEDLINE/PubMed
spelling pubmed-67379612019-09-12 First person – Eileen Lynch Dis Model Mech First Person First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms (DMM), helping early-career researchers promote themselves alongside their papers. Eileen Lynch is first author on ‘C9ORF72-related cellular pathology in skeletal myocytes derived from ALS-patient induced pluripotent stem cells’, published in DMM. Eileen is a graduate research assistant/PhD candidate in the lab of Masatoshi Suzuki at University of Wisconsin-Madison, WI, USA, investigating in vitro disease modeling of neuromuscular diseases. The Company of Biologists Ltd 2019-08-01 2019-08-16 /pmc/articles/PMC6737961/ http://dx.doi.org/10.1242/dmm.041640 Text en © 2019. Published by The Company of Biologists Ltd http://creativecommons.org/licenses/by/4.0This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.
spellingShingle First Person
First person – Eileen Lynch
title First person – Eileen Lynch
title_full First person – Eileen Lynch
title_fullStr First person – Eileen Lynch
title_full_unstemmed First person – Eileen Lynch
title_short First person – Eileen Lynch
title_sort first person – eileen lynch
topic First Person
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6737961/
http://dx.doi.org/10.1242/dmm.041640